The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Levetiracetam Thame 100 mg/ml oral solution



Syri Pharma Limited t/a Thame LaboratoriesPA22697/012/001

Main Information

Trade NameLevetiracetam Thame 100 mg/ml oral solution
Active SubstancesLevetiracetam
Dosage FormOral solution
Licence HolderSyri Pharma Limited t/a Thame Laboratories
Licence NumberPA22697/012/001

Group Information

ATC CodeN03AX Other antiepileptics
N03AX14 levetiracetam

Status

License statusAuthorised
Licence Issued28/08/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0119-171-019
Interchangeable List DocumentPDF of Interchangeable List
« Back